Lung cancer treatment - Biology based decision, from gene to histology

Area of Science:

• Oncology
• Pulmonology
• Medical Research

Background:

• Lung cancer is the leading cause of cancer-related mortality worldwide.
• Current scientific and technological advancements have not significantly reduced lung cancer mortality rates.
• There is a critical need for novel therapeutic strategies tailored to individual patient characteristics.

Purpose of the Study:

• To explore the potential of personalized medicine approaches in lung cancer treatment.
• To identify key challenges hindering the development and implementation of new lung cancer therapies.
• To highlight the promise of targeted therapies and customized chemotherapy for improving patient outcomes.

Main Methods:

• Review of current therapeutic strategies and research directions in lung cancer.
• Analysis of obstacles in sample collection, timely execution, and technology standardization.
• Focus on the potential impact of personalized treatment modalities.

Main Results:

• Despite advancements, lung cancer mortality remains high.
• Significant challenges exist in implementing personalized approaches, including sample collection and technological standardization.
• Targeted therapies and customized chemotherapy are identified as promising avenues.

Conclusions:

• Personalized medicine, specifically targeted therapies and customized chemotherapy, offers significant potential benefits for lung cancer patients.
• Overcoming logistical and technological hurdles is crucial for the successful implementation of these individualized treatment strategies.
• Further research and development in personalized oncology are essential to reduce lung cancer mortality.